Spearhead Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $952K | Sell |
7,093
-57,868
| -89% | -$7.77M | 1.03% | 31 |
|
|
2022
Q2 | $9.95M | Sell |
64,961
-15,510
| -19% | -$2.38M | 1.48% | 20 |
|
|
2022
Q1 | $13M | Sell |
80,471
-4,457
| -5% | -$723K | 1.62% | 18 |
|
|
2021
Q4 | $11.5M | Buy |
84,928
+2,296
| +3% | +$311K | 1.39% | 22 |
|
|
2021
Q3 | $8.91M | Buy |
82,632
+10,880
| +15% | +$1.17M | 1.19% | 41 |
|
|
2021
Q2 | $8.08M | Buy |
71,752
+1,524
| +2% | +$172K | 1.1% | 48 |
|
|
2021
Q1 | $7.6M | Buy |
70,228
+1,540
| +2% | +$167K | 1.12% | 52 |
|
|
2020
Q4 | $7.36M | Buy |
68,688
+6,116
| +10% | +$655K | 1.17% | 29 |
|
|
2020
Q3 | $5.48M | Buy |
62,572
+1,209
| +2% | +$106K | 1.05% | 44 |
|
|
2020
Q2 | $6.03M | Buy |
61,363
+3,570
| +6% | +$351K | 1.29% | 23 |
|
|
2020
Q1 | $4.4M | Sell |
57,793
-199
| -0.3% | -$15.2K | 1.27% | 35 |
|
|
2019
Q4 | $5.14M | Sell |
57,992
-794
| -1% | -$70.3K | 1.28% | 33 |
|
|
2019
Q3 | $4.45M | Buy |
58,786
+7,714
| +15% | +$584K | 1.24% | 38 |
|
|
2019
Q2 | $3.71M | Buy |
51,072
+6,712
| +15% | +$488K | 1.09% | 53 |
|
|
2019
Q1 | $3.58M | Buy |
44,360
+9,335
| +27% | +$752K | 1.08% | 48 |
|
|
2018
Q4 | $3.23M | Sell |
35,025
-1,484
| -4% | -$137K | 1.38% | 29 |
|
|
2018
Q3 | $3.46M | Buy |
36,509
+1,132
| +3% | +$107K | 1.16% | 41 |
|
|
2018
Q2 | $3.28M | Buy |
35,377
+2,835
| +9% | +$263K | 1.17% | 35 |
|
|
2018
Q1 | $3.08M | Buy |
32,542
+5,176
| +19% | +$490K | 1.2% | 35 |
|
|
2017
Q4 | $2.65M | Buy |
+27,366
| New | +$2.65M | 1.29% | 31 |
|